Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial – The Lancet Infectious Diseases Invited commentary: Remdesivir, on the road to DisCoVeRy – The Lancet Infectious Diseases Related: Systematic Review: “Remdesivir probably has little or no […]

The post RCT: Remdesivir does not improve outcomes in patients admitted to hospital with COVID-19. appeared first on Links Medicus.